NasdaqCM - Delayed Quote USD

Aethlon Medical, Inc. (AEMD)

1.4800 +0.0200 (+1.37%)
At close: April 22 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Guy F. Cipriani BS (Eng.), MBA Chief Operating Officer 347.5k -- 1971
Dr. Steven P. LaRosa M.D. Chief Medical Officer 430k -- 1967
Mr. James B. Frakes M.B.A. Interim CEO, CFO, Secretary & Director 385k -- 1957
Dr. Lee D. Arnold Ph.D. Chief Scientific Officer -- -- 1960

Aethlon Medical, Inc.

11555 Sorrento Valley Road
Suite 203
San Diego, CA 92121
United States
619 941 0360 https://www.aethlonmedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
15

Description

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.

Corporate Governance

Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Jun 26, 2024 - Jul 01, 2024
Aethlon Medical, Inc. Earnings Call

Related Tickers

CTSO Cytosorbents Corporation
0.8100
+1.00%
 
61L1.F Sectra AB (publ)
18.09
+1.86%
 
DC4.DE DexCom, Inc.
123.36
+0.64%
 
ENCW Enchanted World Inc.
0.0003
0.00%
 
36M.F Shockwave Medical, Inc.
305.50
-0.68%
 
CVRX CVRx, Inc.
14.69
-1.41%
 
DXCM.VI DexCom, Inc.
123.56
+0.93%
 
BMRA Biomerica, Inc.
0.7247
-0.77%
 
ECOR electroCore, Inc.
5.62
-0.53%
 
BBLGW Bone Biologics Corporation
23.04
-4.68%